On tonight’s MAD MONEY on CNBC, Jim Cramer called for companies with high cash balances to make acquisitions while competitors are dirt cheap and vulnerable. Yesterday, Cramer called for Pfizer (NYSE: PFE) to acquire Allergan (NYSE: AGN) now that Johnson & Johnson (NYSE: JNJ) decided to take out Mentor Corp. (NYSE: MNT) for a huge premium. We recently pondered whether that deal really made Allergan worth less money or more money over the competition. Allergan has been battered as many "self improvements and enhancement surgeries" are being put off because the public is having a major money pinch. Tonight, Cramer gave two more merger candidates and suitors.
RSS Updates
Email Updates
